C4 Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $72k | 38k | 1.91 |
| 2024-03-31 | $1.4M | 174k | 8.17 |
| 2023-12-31 | $950k | 168k | 5.65 |
| 2023-09-30 | $306k | 165k | 1.86 |
| 2023-06-30 | $480k | 174k | 2.75 |
| 2023-03-31 | $358k | 114k | 3.14 |
| 2022-12-31 | $85k | 15k | 5.90 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management